Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study

被引：0
|
作者：
Calabrese, Joseph [1 ]
Sanchez, Raymond [1 ]
Jin, Na [1 ]
Amatniek, Joan [1 ]
Cox, Kevin [1 ]
Johnson, Brian [1 ]
Perry, Pamela P. [1 ]
Hertel, Peter [1 ]
Such, Pedro [1 ]
Salzman, Phyllis M. [1 ]
McQuade, Robert D. [1 ]
Nyilas, Margaretta [1 ]
Carson, William H. [1 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2016年 / 41卷
关键词：
Bipolar I Disorder; Aripiprazole Once-Monthly; Maintenance Treatment; Long-Acting Injectable Antipsychotic;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
T116
引用
收藏
页码：S360 / S361
页数：2
相关论文
共 50 条
  • [1] The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal study
    Calabrese, Joseph R.
    Sanchez, Raymond
    Jin, Na
    Amatniek, Joan
    Cox, Kevin
    Johnson, Brian
    Perry, Pamela P.
    Hertel, Peter
    Such, Pedro
    McQuade, Robert D.
    Nyilas, Margaretta
    Carson, William H.
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 241 : 425 - 432
  • [2] Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder
    Calabrese, Joseph R.
    Sanchez, Raymond
    Jin, Na
    Amatniek, Joan
    Cox, Kevin
    Johnson, Brian
    Perry, Pamela
    Hertel, Peter
    Such, Pedro
    McQuade, Robert D.
    Nyilas, Margaretta
    Carson, William H.
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 227 : 649 - 656
  • [3] Aripiprazole once-monthly for the treatment of adult patients with earlier-stage bipolar I disorder: a post hoc analysis of data from a double-blind, placebo-controlled, 52-week randomized withdrawal trial
    Lynum, Karimah S. Bell
    Castro, Christine F.
    Zhang, Zhen
    Patel, Mehul
    Tohen, Mauricio
    INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS, 2024, 12 (01):
  • [4] Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study
    Joseph R. Calabrese
    Na Jin
    Brian Johnson
    Pedro Such
    Ross A. Baker
    Jessica Madera
    Peter Hertel
    Jocelyn Ottinger
    Joan Amatniek
    Hiroaki Kawasaki
    International Journal of Bipolar Disorders, 6
  • [5] Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study
    Calabrese, Joseph R.
    Jin, Na
    Johnson, Brian
    Such, Pedro
    Baker, Ross A.
    Madera, Jessica
    Hertel, Peter
    Ottinger, Jocelyn
    Amatniek, Joan
    Kawasaki, Hiroaki
    INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS, 2018, 6
  • [6] A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole for the treatment of acute manic or mixed episodes in Asian patients with bipolar I disorder (the AMAZE study)
    Kanba, Shigenobu
    Kawasaki, Hiroaki
    Ishigooka, Jun
    Sakamoto, Kaoru
    Kinoshita, Toshihiko
    Kuroki, Toshihide
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2014, 15 (02) : 113 - 121
  • [7] A randomised, double-blind, placebo-controlled study to evaluate the safety and efficacy of lamotrigine in the maintenance treatment of Chinese adult patients with bipolar I disorder
    Ling Zhang
    Honggeng Zhang
    Lu-xian Lv
    Qingrong Tan
    Xiufeng Xu
    Jian Hu
    Lu Zi
    James Cooper
    Abhay Phansalkar
    Gang Wang
    International Journal of Bipolar Disorders, 10
  • [8] A randomised, double-blind, placebo-controlled study to evaluate the safety and efficacy of lamotrigine in the maintenance treatment of Chinese adult patients with bipolar I disorder
    Zhang, Ling
    Zhang, Honggeng
    Lv, Lu-xian
    Tan, Qingrong
    Xu, Xiufeng
    Hu, Jian
    Zi, Lu
    Cooper, James
    Phansalkar, Abhay
    Wang, Gang
    INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS, 2022, 10 (01)
  • [9] A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia
    Tandon, Rajiv
    Cucchiaro, Josephine
    Phillips, Debra
    Hernandez, David
    Mao, Yongcai
    Pikalov, Andrei
    Loebel, Antony
    JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (01) : 69 - 77
  • [10] Efficacy and safety of aripiprazole once-monthly in Asian patients with schizophrenia: A multicenter, randomized, double-blind, non-inferiority study versus oral aripiprazole
    Ishigooka, Jun
    Nakamura, Jun
    Fujii, Yasuo
    Iwata, Nakao
    Kishimoto, Toshifumi
    Iyo, Masaomi
    Uchimura, Naohisa
    Nishimura, Ryoji
    Shimizu, Naoaki
    SCHIZOPHRENIA RESEARCH, 2015, 161 (2-3) : 421 - 428
12345